Status:

WITHDRAWN

Pulmonary Physiologic Assessment of Patients on Veno-arterial Extracorporeal Membrane Oxygenation (VA ECMO)

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Cardiac Arrest

Pulmonary Injury

Eligibility:

All Genders

18+ years

Brief Summary

There is limited data on the respiratory system mechanics and ideal mode of ventilation for patients on veno-arterial extra-corporeal membrane oxygenation (VA ECMO) post cardiac arrest. In this observ...

Eligibility Criteria

Inclusion

  • On VA ECMO after cardiac arrest
  • Between 18 and 85 years of age
  • Has an orogastric or nasogastric tube with esophageal balloon capabilities in place

Exclusion

  • Known pre-existing significant pulmonary pathology
  • Pacemaker or implanted cardiac defibrillator

Key Trial Info

Start Date :

January 9 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 8 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04739007

Start Date

January 9 2021

End Date

November 8 2022

Last Update

November 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02135